A detailed history of Man Group PLC transactions in Innoviva, Inc. stock. As of the latest transaction made, Man Group PLC holds 457,953 shares of INVA stock, worth $9.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
457,953
Previous 410,337 11.6%
Holding current value
$9.2 Million
Previous $6.25 Million 20.1%
% of portfolio
0.02%
Previous 0.02%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$14.4 - $16.4 $685,670 - $780,902
47,616 Added 11.6%
457,953 $7.51 Million
Q1 2024

May 15, 2024

BUY
$14.56 - $16.78 $464,769 - $535,634
31,921 Added 8.44%
410,337 $6.25 Million
Q4 2023

Feb 14, 2024

SELL
$12.32 - $16.27 $42,491 - $56,115
-3,449 Reduced 0.9%
378,416 $6.07 Million
Q3 2023

Nov 14, 2023

SELL
$12.37 - $13.89 $209,584 - $235,338
-16,943 Reduced 4.25%
381,865 $4.96 Million
Q2 2023

Aug 14, 2023

SELL
$11.39 - $13.72 $209,576 - $252,448
-18,400 Reduced 4.41%
398,808 $5.08 Million
Q1 2023

May 15, 2023

SELL
$10.73 - $13.6 $474,909 - $601,936
-44,260 Reduced 9.59%
417,208 $4.69 Million
Q4 2022

Feb 14, 2023

SELL
$11.8 - $13.78 $287,719 - $335,997
-24,383 Reduced 5.02%
461,468 $6.11 Million
Q3 2022

Nov 14, 2022

BUY
$11.61 - $15.22 $640,314 - $839,413
55,152 Added 12.81%
485,851 $5.64 Million
Q2 2022

Aug 15, 2022

BUY
$14.32 - $19.88 $1.92 Million - $2.66 Million
133,824 Added 45.08%
430,699 $6.36 Million
Q1 2022

May 16, 2022

BUY
$15.39 - $20.25 $635,037 - $835,575
41,263 Added 16.14%
296,875 $5.75 Million
Q4 2021

Feb 14, 2022

BUY
$15.91 - $18.72 $396,890 - $466,989
24,946 Added 10.81%
255,612 $4.41 Million
Q3 2021

Nov 15, 2021

BUY
$13.06 - $17.24 $33,969 - $44,841
2,601 Added 1.14%
230,666 $3.85 Million
Q2 2021

Aug 16, 2021

SELL
$11.45 - $13.96 $54,490 - $66,435
-4,759 Reduced 2.04%
228,065 $3.06 Million
Q1 2021

May 17, 2021

SELL
$11.06 - $12.87 $7.94 Million - $9.24 Million
-718,220 Reduced 75.52%
232,824 $2.78 Million
Q4 2020

Feb 16, 2021

SELL
$9.33 - $12.48 $7.45 Million - $9.96 Million
-798,145 Reduced 45.63%
951,044 $11.8 Million
Q3 2020

Nov 16, 2020

BUY
$10.33 - $14.49 $5.52 Million - $7.74 Million
534,405 Added 43.99%
1,749,189 $18.3 Million
Q2 2020

Aug 14, 2020

SELL
$11.49 - $15.26 $398,048 - $528,652
-34,643 Reduced 2.77%
1,214,784 $17 Million
Q1 2020

May 15, 2020

SELL
$8.11 - $15.23 $615,419 - $1.16 Million
-75,884 Reduced 5.73%
1,249,427 $14.7 Million
Q4 2019

Feb 18, 2020

SELL
$10.28 - $14.38 $1.9 Million - $2.66 Million
-185,238 Reduced 12.26%
1,325,311 $18.8 Million
Q3 2019

Nov 14, 2019

SELL
$10.05 - $14.55 $6.16 Million - $8.93 Million
-613,423 Reduced 28.88%
1,510,549 $15.9 Million
Q2 2019

Aug 14, 2019

BUY
$13.1 - $14.95 $1.95 Million - $2.23 Million
148,941 Added 7.54%
2,123,972 $30.9 Million
Q1 2019

May 15, 2019

BUY
$13.69 - $20.06 $4.6 Million - $6.74 Million
335,954 Added 20.5%
1,975,031 $27.7 Million
Q4 2018

Feb 14, 2019

BUY
$13.96 - $18.26 $6.48 Million - $8.47 Million
464,068 Added 39.49%
1,639,077 $28.6 Million
Q3 2018

Nov 14, 2018

BUY
$13.63 - $15.7 $2.25 Million - $2.59 Million
164,942 Added 16.33%
1,175,009 $17.9 Million
Q2 2018

Aug 14, 2018

SELL
$13.44 - $17.59 $514,859 - $673,837
-38,308 Reduced 3.65%
1,010,067 $13.9 Million
Q1 2018

May 15, 2018

BUY
$13.8 - $16.99 $14.5 Million - $17.8 Million
1,048,375 New
1,048,375 $17.5 Million

Others Institutions Holding INVA

About Innoviva, Inc.


  • Ticker INVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,706,000
  • Market Cap $1.4B
  • Description
  • Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...
More about INVA
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.